Get notified when RDNT files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsrevenue $622.7M, net income $7.5M. RadNet Q2 2026: Revenue +25% on acquisitions, but net income -48% as below-the-line costs rise
Filed August 10, 2026 · Period ending June 30, 2026 · Compared to 10-Q Aug 11, 2025 · ~2 min read
Key Changes
-
high
Net income to common fell 47.9% to $7.5M despite operating income rising 27.8% to $39.5M, driven by $15.5M in higher below-the-line costs (non-operating/other -$5.8M, income tax -$5.5M, noncontrolling interest -$4.1M).
MD&A: Earnings Quality verify on EDGAR → -
high
Acquired 24 imaging centers for $86M in H1 2026 (Florida, Indiana, Idaho) vs 6 centers for $16.4M in H1 2025; total center count reached 442, up 37 net centers YoY.
MD&A: Acquisitions verify on EDGAR → -
high
Same-center revenue growth accelerated to 11.1% in Q2 2026 from 4.4% in Q2 2025, driven by higher fees and volume growth in PET/CT procedures for prostate cancer and Alzheimer's studies.
MD&A: Same-Center Growth verify on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (SPWH 10-Q) is open in full — no account needed.
Partner
Trade RDNT commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Aug 11, 2026 · How we verify